Humacyte outlines 12-month cash runway and accelerates Symvess adoption following $56.5M capital raise
Source: SeekingAlpha
2025-11-12 12:22:21 ET
More on Humacyte
- Humacyte, Inc. (HUMA) Q3 2025 Earnings Call Transcript
- Humacyte: Shares Tank On Fundraising News - What You Need To Know
- Humacyte Q3 2025 Earnings Preview
- Humacyte shares sink as it announces pricing of $60M direct offering
- Seeking Alpha’s Quant Rating on Humacyte
Read the full article on Seeking Alpha
For further details see:
Humacyte outlines 12-month cash runway and accelerates Symvess adoption following $56.5M capital raise
Humacyte Inc. Warrant
NASDAQ: HUMAW
HUMAW Trading
10.37% G/L:
$0.1181 Last:
5,004 Volume:
$0.1087 Open:
HUMAW Latest News
HUMAW Stock Data
$247,325,345
156,832,240
N/A
62
N/A
Biotechnology & Life Sciences
Healthcare
US
Durham
